GeneReach Biotechnology Corp.

4171

TW0004171004

Pharmaceuticals

End-of-day quote Taipei Exchange Other stock markets 23:00:00 09/05/2024 BST			5-day change	1st Jan Change
32.05 ^TWD	-0.93%		-0.31%	-18.76%

03-28	GeneReach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	GeneReach Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

GeneReach Biotechnology Corp.(GTSM:4171) added to S&P Global BMI Index

September 21, 2020 at 05:00 am

Latest news about GeneReach Biotechnology Corp.

GeneReach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
GeneReach Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
GeneReach Biotechnology Corp.(TPEX:4171) dropped from S&P Global BMI Index	18/09/23	CI
GeneReach Biotechnology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/08/23	CI
GeneReach Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
GeneReach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23	CI
GeneReach Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	10/11/22	CI
GeneReach Biotechnology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/08/22	CI
GeneReach Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	09/05/22	CI
GeneReach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	21/03/22	CI
Taiwan's OBI Pharma Grants Experimental Drug Rights to Odeon Therapeutics (Hong Kong)	24/02/22	MT
GeneReach Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	11/11/21	CI
Genereach Biotechnology Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	09/08/21	CI
Genereach Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	13/05/21	CI
Genereach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2020	29/03/21	CI
Genereach Biotechnology Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2020	10/11/20	CI
GeneReach Biotechnology Corp.(GTSM:4171) added to S&P Global BMI Index	21/09/20	CI
Genereach Biotechnology Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2020	12/08/20	CI
Genereach Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2020	14/05/20	CI
Genereach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2019	29/03/20	CI
Genereach Biotechnology Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2019	13/11/19	CI
Genereach Biotechnology Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2019	12/08/19	CI
Genereach Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2019	14/05/19	CI
Genereach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2018	29/03/19	CI
Genereach Biotechnology Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2018	12/11/18	CI

Chart GeneReach Biotechnology Corp.

Duration

Period

More charts

GeneReach Biotechnology Corp. is principally engaged in the manufacture and distribution of animal testing equipment and testing agents. The Company mainly operates through Taiwan segment. The Company provides shrimp virus testing agents, on-site detection systems for fish and shrimp, mini centrifugal machines, pet disease testing agents and other testing equipment.

Sector

Pharmaceuticals

More about the company